Eradication of tuberculosis by 2050 impossible without new vaccineBMJ 2009; 338 doi: http://dx.doi.org/10.1136/bmj.b1291 (Published 27 March 2009) Cite this as: BMJ 2009;338:b1291
- Richard Smith
- 1Rio de Janeiro
The search for new drugs and vaccines to target tuberculosis has seen a “phenomenal sea change,” with more than 20 products in the pipeline, delegates heard at the Simply, Stopping Tuberculosis conference in Rio de Janeiro.
However, Jerald Sadoff, president of Aeras Global TB Vaccine Foundation, warned that the aim of the Stop TB Partnership to eradicate the disease by 2050 will be unreachable without a new vaccine. The existing vaccine, BCG, works in only 15-40% of children and possibly not at all in adults, he said.
The conference heard that the main …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial